Maha Narayana Thailam
Maha Narayana Thailam is a classical Ayurvedic taila, a medicated oil. Listed in Ayurvedic Formulary of India (AFI) Part I. Bhaishajya Ratnavali (Vatavyadhi Chikitsa, verses 151-162) by Govind Das Sen. The 'Maha' (great) version is an expanded formulation of Narayana Thailam with 50-56+ herbs including the rare Ashtavarga group.
| Also known as | Maha Narayana Thailam, MahaNarayanaThailam |
|---|---|
| Pharmacopoeia status | Listed in Ayurvedic Formulary of India (AFI) Part I. Primary reference in Bhaishajya Ratnavali. Also documented in Sahasrayogam (South Indian tradition). Manufactured by major licensed pharmacies (Kottakkal AVS, AVP, Nagarjuna) under AYUSH GMP certification. |
Names and identification
| Language | Name |
|---|---|
| English | Maha Narayana Thailam |
Where is it described in the classical texts?
Bhaishajya Ratnavali (Vatavyadhi Chikitsa, verses 151-162) by Govind Das Sen. The ‘Maha’ (great) version is an expanded formulation of Narayana Thailam with 50-56+ herbs including the rare Ashtavarga group. Also referenced in Sushruta Samhita commentaries.
How does it work?
- Withanolides from Ashwagandha suppress NF-kB pathway activation, reducing inflammatory cytokines (TNF-alpha, IL-6) at joint tissue level
- Sesame oil base serves as a penetration enhancer, delivering lipophilic saponins, lignans, and phenolics transdermally to deep musculoskeletal tissues
- Guduchi’s berberine and tinosporine alkaloids provide immunomodulatory and anti-arthritic effects by modulating T-cell response and reducing rheumatoid factor
- Rasna’s clerodane diterpenes provide specific anti-inflammatory action on synovial membranes, reducing joint swelling and stiffness
Which traditional uses are supported by research?
- Osteoarthritis and joint pain management - validated by AYU Journal study (2018) showing 68% symptom reduction with 21 days of Abhyanga treatment
- Vata-vyadhi (neuromuscular disorders) including paralysis, muscular atrophy, and tremors - supported by pharmacological studies confirming neuroprotective and anti-inflammatory compounds
- Bone and joint strengthening (Asthi-Sandhi Balya) - supported by the identification of phytosterols and calcium-channel active compounds from Dashamoola and Ashwagandha
What do recent clinical trials show?
3 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- Generally safe for external application. Some individuals with sensitive skin may experience mild warmth or redness due to heating herbs. Not recommended for acute inflammatory pitta conditions or open wounds. Patch test advised for first-time users.
- Internal administration should only be under practitioner supervision. Caution in individuals on blood-thinning medications due to potential interaction with anti-inflammatory phytoconstituents. Heavy formulation may not be suitable for daily use in Kapha-dominant individuals.
What is it made of?
Key Active Markers
- Derived from constituent herbs (see individual herb profiles)
- Standardized on primary bioactive markers
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Thailam (medicated sesame oil), External application
Standard Dosage: External massage or Basti (enema): 30-60ml
Bioavailability: Oil base (sesame oil) enhances dermal absorption of lipophilic active compounds; for internal thailams, oil base enhances absorption of fat-soluble actives
Optimal Timing: External: before bath or at bedtime. Internal: before meals
Shelf Life: 3 years (medicated oils per ASU guidelines)
Storage: Airtight amber glass/HDPE container, room temperature, protected from light
Marker Compounds: Withanolides, Aegeline, Sesamin
Quality Parameters: Acid value <5, saponification value per base oil specs, refractive index, moisture NMT 0.5%, specific gravity, marker: Withanolides, Aegeline, Sesamin
Vehicle (Anupana): External: massage into affected area. Internal: with warm water/milk
Synergistic Combinations
- Key herbs: Bilva, Ashwagandha, Brihati, Shatavari + 20 more herbs; oil base acts as lipid carrier for enhanced tissue penetration
Composition
As given in the Ayurvedic Formulary of India, Part I, entry 8:45 (MAHA NARAYANA TAILA), which cites Bhaisajyaratnavali, Vatavyadhyadhikara; 151-157.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Bilva | Rt. /St. Bk. | 960 g. |
| 2 | Asvagandha | root | 960 g. |
| 3 | Brhati * | illegible | 960 g. |
| 4 | Svadamistra (goksura) * | illegible | 960 g. |
| 5 | Syonaka * | Rt. St. Bk. | 960 2. |
| 6 | Vatyalaka (bala) * | illegible | 960 g. |
| 7 | Paribhadra | root | 960 g. |
| 8 | Ksudra (kantakari) * | illegible | 960 g. |
| 9 | Kathilla (rakta punarnava) * | illegible | 960 g. |
| 10 | Atibala * | root | 960 g. |
| 11 | Agnimantha * | Rt./St. Bk. | 960 g. |
| 12 | Sarani (prasarini) * | illegible | 960 g. |
| 13 | Patali (patala) * | Rt./St.Bk. | 960 2. |
| 14 | Water for decoction / reduced to * | 98.304 I. / reduced to 24.576 I. | |
| 15 | Taila (tila) * | oil | 6.144 kg. |
| 16 | Aja dugdha or Go dugdha * | 6.144 kg. | |
| 17 | Satavari-rasa * | root tuber | 6.144 1. |
| 18 | Rasna | Rt./Lf. | 96 g. |
| 19 | Asvagandha | root | 96 g. |
| 20 | Misi (misreya) * | Fr, | 96 g. |
| 21 | Daru (devadaru) * | heart wood | 96 g. |
| 22 | Kustha | root | 96 g. |
| 23 | Salaparni * | illegible | 96 g. |
| 24 | Prsniparni * | PC | 96 g. |
| 25 | Mudgaparni * | illegible | 96 g. |
| 26 | Masaparni * | illegible | 96 g. |
| 27 | Agaru * | heart wood | 96 g. |
| 28 | KeSara (nagakeSara) * | stamens | 96 £. |
| 29 | Sindhuttha (saindhava lavana) * | 96 g. | |
| 30 | Mamsi (jafamamsi) * | Rz./Rt. | 96 g. |
| 31 | Haridra * | rhizome | 96 g. |
| 32 | Daruharidra | stem | 96 g. |
| 33 | Saileyaka (Saileya) * | illegible | 96 g. |
| 34 | Candana (rakta - candana) | heart wood | 96 g. |
| 35 | Puskara * | root | 96 £. |
| 36 | Ela (suksmaila) | seed | 96 g. |
| 37 | Asra (manjistha) | root | 96 g. |
| 38 | Yasti | root | 96 g. |
| 39 | Tagara | Rt./Rz. | 96 g. |
| 40 | Abda (musta) | rhizome | 96 g. |
| 41 | Patra (tejapatra) | leaf | 96 g. |
| 42 | Bhrnga (tvak) | stem bark | 96 g. |
| 43 | Jivaka | root tuber | 96 g. |
| 44 | Rsabhaka * | root tuber | 96 £. |
| 45 | Meda * | Tr..Rt. | 96 g. |
| 46 | Mahameda | root tuber | 96 g. |
| 47 | Kakoli | Sub. Rt. | 96 g. |
| 48 | Ksira Kakoli | Sub.Rt. | 96 g. |
| 49 | Rddhi | Sub. Rt.Tr. | 96 g. |
| 50 | Vrddhi | Sub. Rt. Tr. | 96 g. |
| 51 | Ambu (hrivera) | root | 96 g. |
| 52 | Vaca | rhizome | 96 g. |
| 53 | Palasa | stem bark | 96 g. |
| 54 | Sthauneya | stem bark | 96 g. |
| 55 | Vrsciraka (Sveta punarnava) * | illegible | 96 g. |
| 56 | Coraka | rhizome | 96 g. |
| 57 | Karpura | Sub. Ext. | 48 g. |
| 58 | Kasmira (kunkuma) | Stl./ Stg. | 48 g. |
| 59 | Mrgandaja (mrgamada) * | 48 g. |
Cells marked illegible are damaged in the source scan. The ingredient name is shown where it was readable, and nothing is inferred to fill a gap.
* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.